<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32250500</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>SOD1 p.D12Y variant is associated with amyotrophic lateral sclerosis/distal myopathy spectrum.</ArticleTitle><Pagination><StartPage>1304</StartPage><EndPage>1309</EndPage><MedlinePgn>1304-1309</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.14246</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">The aim of our study was to describe patients with the p.D12Y variant (previously reported as D11Y) in SOD1 showing heterogeneous clinicopathological features.</AbstractText><AbstractText Label="METHODS">We performed clinical, electrophysiological, magnetic resonance imaging (MRI) and muscle pathology studies in four SOD1 p.D12Y variant-positive patients.</AbstractText><AbstractText Label="RESULTS">The SOD1 p.D12Y clinical manifestations ranged from a benign phenotype characterized by distal distribution of muscular weakness and long survival to classic forms of amyotrophic lateral sclerosis with poor prognosis. Two patients with the distal clinical phenotype showed MRI and muscle pathology alterations indicating a concurrent muscle involvement. In one of these patients significant myopathic changes were associated with rimmed vacuolar pathology.</AbstractText><AbstractText Label="CONCLUSIONS">We expand the clinical spectrum of SOD1 p.D12Y variant, including predominant lower motor neuron forms with long survival and classic forms with aggressive course. Some patients may have concomitant distal myopathy without other explanations. Given clinical, MRI and muscle pathology alterations, SOD1 should be considered in the differential diagnosis of molecularly undefined distal myopathies with rimmed vacuoles.</AbstractText><CopyrightInformation>&#xa9; 2020 European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tasca</LastName><ForeName>G</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0849-9144</Identifier><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lattante</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Genetica Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto di Medicina Genomica, Universit&#xe0; Cattolica del Sacro Cuore, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marangi</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Genetica Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto di Medicina Genomica, Universit&#xe0; Cattolica del Sacro Cuore, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conte</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Clinico NEMO, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardo</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro Clinico NEMO, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisogni</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centro Clinico NEMO, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandich</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zollino</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Genetica Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto di Medicina Genomica, Universit&#xe0; Cattolica del Sacro Cuore, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragozzino</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Istituto di Neurologia, Universit&#xe0; Cattolica del Sacro Cuore, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udd</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Folkh&#xe4;lsan Research Center, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuromuscular Research Center, Tampere University and University Hospital, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabatelli</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6635-4985</Identifier><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Clinico NEMO, Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto di Neurologia, Universit&#xe0; Cattolica del Sacro Cuore, Roma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>ICOMM Association</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049310" MajorTopicYN="Y">Distal Myopathies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="N">Muscle Weakness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">all neuromuscular disease</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">distal myopathy</Keyword><Keyword MajorTopicYN="N">muscle disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32250500</ArticleId><ArticleId IdType="doi">10.1111/ene.14246</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res 2015; 1607: 75-93.</Citation></Reference><Reference><Citation>Sabatelli M, Conte A, Zollino M. Clinical and genetic heterogeneity of amyotrophic lateral sclerosis. Clin Genet 2013; 83: 408-416.</Citation></Reference><Reference><Citation>Del Grande A, Conte A, Lattante S, et al. D11Y SOD1 mutation and benign ALS: a consistent genotype-phenotype correlation. J Neurol Sci 2011; 309: 31-33.</Citation></Reference><Reference><Citation>Georgoulopoulou E, Gellera C, Bragato C, et al. A novel SOD1 mutation in a young amyotrophic lateral sclerosis patient with a very slowly progressive clinical course. Muscle Nerve 2010; 42: 596-597.</Citation></Reference><Reference><Citation>Tasca G, Ricci E, Penttil&#xe4; S, et al. New phenotype and pathology features in MYH7-related distal myopathy. Neuromuscul Disord 2012; 22: 640-647.</Citation></Reference><Reference><Citation>Tasca G, Ricci E, Monforte M, et al. Muscle imaging findings in GNE myopathy. J Neurol 2012; 259: 1358-1365.</Citation></Reference><Reference><Citation>Tasca G, Monforte M, Iannaccone E, et al. Upper girdle imaging in facioscapulohumeral muscular dystrophy. PLoS ONE 2014; 9: e100292.</Citation></Reference><Reference><Citation>Marangi G, Lattante S, Doronzio PN, et al. Matrin 3 variants are frequent in Italian ALS patients. Neurobiol Aging 2017; 49: 218.e1-218.e7.</Citation></Reference><Reference><Citation>Evil&#xe4; A, Arumilli M, Udd B, Hackman P. Targeted next-generation sequencing assay for detection of mutations in primary myopathies. Neuromuscul Disord 2016; 26: 7-15.</Citation></Reference><Reference><Citation>Lattante S, Marangi G, Luigetti M, et al. Founder effect hypothesis of D11Y SOD1 mutation in Italian amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler 2012; 13: 241-242.</Citation></Reference><Reference><Citation>Watts GDJ, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin containing protein. Nat Genet 2004; 36: 377-381.</Citation></Reference><Reference><Citation>Johnson JO, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010; 68: 857-864.</Citation></Reference><Reference><Citation>Palmio J, Sandell S, Suominen T, et al. Distinct distal myopathy phenotype caused by VCP gene mutation in a Finnish family. Neuromuscul Disord 2011; 21: 551-555.</Citation></Reference><Reference><Citation>Kim HJ, Kim NC, Wang YD, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 2013; 495: 467-473.</Citation></Reference><Reference><Citation>Senderek J, Garvey SM, Krieger M, et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet 2009; 84: 511-518.</Citation></Reference><Reference><Citation>M&#xfc;ller TJ, Kraya T, Stoltenburg-Didinger G, et al. Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 2014; 76: 669-680.</Citation></Reference><Reference><Citation>Johnson JO, Pioro EP, Boehringer A, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci 2014; 17: 664-666.</Citation></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 2011; 68: 1440-1446.</Citation></Reference><Reference><Citation>Bucelli RC, Arhzaouy K, Pestronk A, et al. SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles. Neurology 2015; 85: 665-674.</Citation></Reference><Reference><Citation>Ghaoui R, Palmio J, Brewer J, et al. Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathy. Neurology 2016; 86: 391-398.</Citation></Reference><Reference><Citation>Nishino I. Autophagic vacuolar myopathies. Curr Neurol Neurosci Rep 2003; 3: 64-69.</Citation></Reference><Reference><Citation>Dobrowolny G, Aucello M, Rizzuto E, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 2008; 8: 425-436.</Citation></Reference><Reference><Citation>Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet 2010; 19: 2284-2302.</Citation></Reference><Reference><Citation>Crociara P, Chieppa MN, Vallino Costassa E, et al. Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALS. Neurobiol Dis 2018; 124: 263-275.</Citation></Reference><Reference><Citation>Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 2006; 7: 710-723.</Citation></Reference><Reference><Citation>Morimoto N, Nagai M, Ohta Y, et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res 2007; 1167: 112-117.</Citation></Reference><Reference><Citation>Li L, Zhang X, Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy 2008; 4: 290-293.</Citation></Reference><Reference><Citation>Nguyen DKH, Thombre R, Wang J. Autophagy as a common pathway in amyotrophic lateral sclerosis. Neurosci Lett 2019; 697: 34-48.</Citation></Reference><Reference><Citation>Sabatelli M, Marangi G, Conte A, Tasca G, Zollino M, Lattante S. New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis. Brain Pathol 2016; 26: 266-275.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>